Caption Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Caption Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69M	Buy	+120,877	New	+$2.89M	0.02%	738
2025 Q3	–	Sell	-8,455	Closed	-$200K	–	1613
2025 Q2	$182K	Sell	8,455 -56,769	-87%	-$1.06M	﹤0.01%	1271
2025 Q1	$1.08M	Buy	+65,224	New	+$1.18M	0.01%	885
2024 Q3	–	Sell	-7,800	Closed	-$130K	–	1231
2024 Q2	$127K	Sell	7,800 -58,800	-88%	-$949K	﹤0.01%	1002
2024 Q1	$1.23M	Buy	+66,600	New	+$1.65M	0.02%	679
2022 Q3	–	Sell	-1,766	Closed	-$28.6K	–	1459
2022 Q2	$25K	Sell	1,766 -17,034	-91%	-$318K	﹤0.01%	1360
2022 Q1	$455K	Buy	+18,800	New	+$455K	0.01%	1156
2021 Q4	–	Sell	-21,500	Closed	-$432K	–	1543
2021 Q3	$357K	Sell	21,500 -35,500	-62%	-$684K	﹤0.01%	1259
2021 Q2	$1.39M	Sell	57,000 -54,700	-49%	-$1.23M	0.02%	800
2021 Q1	$2.88M	Buy	111,700 +51,100	+84%	+$2.25M	0.06%	407
2020 Q4	$3.24M	Buy	60,600 +25,600	+73%	+$1.27M	0.07%	319
2020 Q3	$1.44M	Sell	35,000 -15,457	-31%	-$667K	0.03%	527
2020 Q2	$2.45M	Buy	+50,457	New	+$2.42M	0.08%	328
2020 Q1	–	Sell	-20,700	Closed	-$885K	–	824
2019 Q4	$885K	Sell	20,700 -4,300	-17%	-$187K	0.03%	525
2019 Q3	$899K	Buy	+25,000	New	+$758K	0.05%	399
2018 Q3	–	Sell	-36,000	Closed	-$549K	–	497
2018 Q2	$549K	Buy	+36,000	New	+$642K	0.04%	313

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Caption Management's ACAD Position: Q1 2026 in Review

Caption Management opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2026: 120,877 shares worth $2.69M. The stake represents 0.02% of the portfolio and ranks #738 among its holdings. This is a return to the name: Caption Management previously reported a position in ACAD as recently as Q2 2025.

Caption Management first reported a position in ACAD in Q2 2018 and has held it in 16 quarters since. The position peaked at $3.24M in Q4 2020. 341 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Caption Management held 120,877 shares of Acadia Pharmaceuticals worth $2.69M as of Q1 2026.
Acadia Pharmaceuticals was a new Caption Management position in Q1 2026.
Acadia Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q1 2026, its #738 holding.
Caption Management first reported a position in Acadia Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
Caption Management's Acadia Pharmaceuticals position peaked at $3.24M in Q4 2020.
341 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.